GSA Capital Partners’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-80,876
| Closed | -$219K | – | 1736 |
|
|
2021
Q1 | $219K | Sell |
80,876
-49,869
| -38% | -$135K | 0.04% | 848 |
|
|
2020
Q4 | $316K | Buy |
+130,745
| New | +$316K | 0.05% | 705 |
|
|
2018
Q2 | – | Sell |
-29,258
| Closed | -$246K | – | 2071 |
|
|
2018
Q1 | $246K | Buy |
29,258
+21,283
| +267% | +$179K | 0.01% | 1389 |
|
|
2017
Q4 | $74K | Buy |
7,975
+1,812
| +29% | +$16.8K | ﹤0.01% | 1489 |
|
|
2017
Q3 | $72K | Buy |
6,163
+3,763
| +157% | +$44K | ﹤0.01% | 1539 |
|
|
2017
Q2 | $100K | Buy |
+2,400
| New | +$100K | 0.01% | 1590 |
|